NetMHCIIphosPan: A Machine Learning Tool for Predicting HLA Class II Antigen Presentation of Phosphorylated Peptides

Area of Science:

• Immunology
• Computational Biology
• Proteomics

Background:

• Phosphorylated peptides presented by human leukocyte antigen (HLA) class II molecules are crucial for immune regulation.
• Characterizing and predicting these phosphorylated peptides is challenging due to data noise and limited HLA coverage.

Purpose of the Study:

• To introduce NetMHCIIphosPan, a novel prediction method for HLA class II antigen presentation of phosphorylated peptides.
• To improve the prediction accuracy of HLA-II presented phosphorylated peptides using mass spectrometry (MS)-based immunopeptidomics data.

Main Methods:

• Reanalyzed existing HLA-II phospholigand datasets using a refined peptide identification workflow.
• Trained predictive models incorporating both phosphorylated and unmodified ligands.
• Performed binding motif analysis to understand HLA-specific preferences.

Main Results:

• NetMHCIIphosPan demonstrated superior performance compared to models trained on original data.
• HLA-specific preferences for phospholigands aligned with those of unmodified ligands.
• Incorporating unmodified ligands enhanced predictive accuracy, especially for HLA-DP and HLA-DQ.
• NetMHCIIphosPan outperformed existing prediction tools for phosphorylated peptides.

Conclusions:

• NetMHCIIphosPan is a robust and state-of-the-art tool for analyzing the HLA-II phospholigandome.
• The findings provide valuable insights into HLA-II antigen presentation of phosphorylated peptides.
• NetMHCIIphosPan has potential applications in immunotherapy and vaccine design.